CHANGES IN NERVE FUNCTION AND DISABILITY IN LEPROSY PATIENTS WHILE ON TREATMENT
Not Applicable
- Conditions
- Health Condition 1: A309- Leprosy, unspecified
- Registration Number
- CTRI/2022/02/039908
- Lead Sponsor
- PGIMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients who give valid consent/assent.
2.Patients of either gender with age 14 and above.
3.All patients being started on anti-leprosy treatment: multidrug therapy (MDT) or alternative therapy in cases with drug resistanceas per WHO guidelines69
Exclusion Criteria
1.Patients who are not willing to provide consent for the study.
2.Patient of age <14 years
3.Patients at risk of a neuropathy other than leprosy, i.e. diabetes, alcoholism, risk group for HIV infection, patients with a family history of hereditary neuropathy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess nerve function impairment(NFI) and disability status in leprosy patients on anti-leprosy treatment(ALT)Timepoint: Will be done as 3 monthly assessment till 1 year study period
- Secondary Outcome Measures
Name Time Method To study the predictors of changes (improvement or worsening) in nerve function impairment(NFI)Timepoint: 1 year